We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$984M
AUM Growth
+$75.1M
Cap. Flow
+$13.9M
Cap. Flow %
1.41%
Top 10 Hldgs %
54.55%
Holding
135
New
7
Increased
20
Reduced
9
Closed
8

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$11.9M
2
AMGN icon
Amgen
AMGN
+$2.76M
3
GILD icon
Gilead Sciences
GILD
+$2.63M
4
BIIB icon
Biogen
BIIB
+$1.96M
5
CELG
Celgene Corp
CELG
+$1.61M

Sector Composition

Rank Sector Weight
1 Financials 35.78%
2 Healthcare 22.27%
3 Industrials 11.22%
4 Technology 7.01%
5 Consumer Staples 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
126
Acadia Pharmaceuticals
ACAD
$5.07B
-60,000
Closed -$916K
AEIS icon
127
Advanced Energy
AEIS
$13.1B
-3,830
Closed -$222K
CORT icon
128
Corcept Therapeutics
CORT
$12.1B
-30,000
Closed -$472K
DLX icon
129
Deluxe
DLX
$1.09B
-3,440
Closed -$228K
RMAX icon
130
RE/MAX Holdings
RMAX
$258M
-4,470
Closed -$234K
SYF icon
131
Synchrony
SYF
$25.5B
-6,300
Closed -$210K
AKAO
132
DELISTED
Achaogen Inc
AKAO
-60,000
Closed -$520K

Similar funds

Hikari Power's Q3 2018 Portfolio in Review

As of Q3 2018, Hikari Power held 135 positions worth $984M, up 8.3% from $908M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Hikari Power's Q3 2018 filing shows 7 new, 20 increased, 9 reduced and 8 closed positions. Its largest new stake was Bank of New York Mellon: 25,300 shares worth $1.29M. The largest sale was IBM, an estimated $11.9M.

By sector, the portfolio is most concentrated in Financials at 36% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q3 2018 buy was Bank of New York Mellon: 25,300 shares worth $1.29M.
  • Hikari Power added most to Allergan plc in Q3 2018, an estimated $6.77M increase.
  • Hikari Power's biggest Q3 2018 reduction was IBM, cutting an estimated $11.9M.
  • Hikari Power fully exited Acadia Pharmaceuticals in Q3 2018, selling an estimated $916K.
  • Hikari Power's ten largest holdings make up 55% of its $984M portfolio in Q3 2018.
  • Hikari Power opened 7 new positions and closed 8 in Q3 2018.
  • Hikari Power's portfolio value rose 8.3% quarter-over-quarter to $984M.

Based on Hikari Power's 13F filing for Q3 2018, filed 31 Oct 2018.